image

The best stocks to buy since 1993

Latest issue now available

Growth Portfolio 2 - February

February 2007

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Another tremendous month for Growth Portfolio 2; after last month's eyewatering gain of 14.4%, the portfolio rose 4.3%, nicely outperforming the benchmarks. That gain is mostly the result of continuing outstanding performances from Renesola and Caretech, both up over £1 on the month. As a result, the portfolio has now quintupled since operations started and stands at a record high. With Renesola soaring to 610p at one point, a rise of 276% since we bought them just three months ago, we couldn’t resist locking in some profits. 3,000 shares went at 570p. We also decided to topslice two of our other recent strong performers with 2,000 Scott Wilson sold at 315p and 2,000 Wilmington sold at 250p, showing gains of 68% and 16 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe